Severe drug shortages impose heavy costs on hospital pharmacies: Senate bill might help... or not

P and T

Volumn 36, Issue 5, 2011, Pages 242-302

  Barlas, Stephen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANESTHETIC AGENT; ANTIEMETIC AGENT; CYTARABINE; DEXAMETHASONE; NORADRENALIN; PRESCRIPTION DRUG; PROPOFOL; PROPOVEN; UNCLASSIFIED DRUG;

ARTICLE; DRUG INDUSTRY; DRUG LEGISLATION; DRUG MANUFACTURE; DRUG STORAGE; DRUG UTILIZATION; FOOD AND DRUG ADMINISTRATION; GOOD MANUFACTURING PRACTICE; HEALTH CARE; HOSPITAL COST; HOSPITAL PHARMACY; HUMAN; INJECTION; LIPOSOMAL DELIVERY; MEDICAL SOCIETY; PHARMACIST;

EID: 79958244282     PISSN: 10521372     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (1)

1. Drug shortages cost U.S. care providers at least $200 million annually, pose patient safety risks, research suggests. Charlotte, N.C.: Premier, Inc.; March 28, 2011. Available at: www.premierinc.com/about/news/11-mar/drugshortage032811.jsp. Accessed March 30, 2011.